Variant report
Variant | esv3503327 |
---|---|
Chromosome Location | chr11:5759326-5763399 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:5757074..5759023-chr11:5763300..5765136,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000181023 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77499372 | chr11:5759331-5759332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9666140 | chr11:5759341-5759342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181909177 | chr11:5759354-5759355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553317741 | chr11:5759364-5759365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574958397 | chr11:5759375-5759376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375789354 | chr11:5759388-5759389 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186985122 | chr11:5759417-5759418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115162890 | chr11:5759435-5759436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531065151 | chr11:5759441-5759442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546227426 | chr11:5759448-5759449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564438605 | chr11:5759449-5759450 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9665780 | chr11:5759460-5759461 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs553825051 | chr11:5759488-5759489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12576875 | chr11:5759509-5759510 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs77699127 | chr11:5759525-5759526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112452271 | chr11:5759540-5759541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577246196 | chr11:5759600-5759601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74051094 | chr11:5759613-5759614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76313093 | chr11:5759629-5759630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539309471 | chr11:5759640-5759641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76410944 | chr11:5759641-5759642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556821903 | chr11:5759658-5759659 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs202120077 | chr11:5759667-5759668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566108501 | chr11:5759680-5759681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533672628 | chr11:5759685-5759686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34303893 | chr11:5759704-5759705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150908982 | chr11:5759708-5759709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188513236 | chr11:5759729-5759730 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574978037 | chr11:5759755-5759756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375392721 | chr11:5759768-5759769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546941951 | chr11:5759775-5759776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368031780 | chr11:5759777-5759778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576021849 | chr11:5759832-5759833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545039503 | chr11:5759835-5759836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558621933 | chr11:5759847-5759848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546490856 | chr11:5759859-5759860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571548745 | chr11:5759865-5759866 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573259393 | chr11:5759867-5759868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540412800 | chr11:5759919-5759920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs58261157 | chr11:5759997-5759998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74451719 | chr11:5760005-5760006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75341493 | chr11:5760006-5760007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529326252 | chr11:5760021-5760022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78159603 | chr11:5760040-5760041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369619083 | chr11:5760088-5760089 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117295829 | chr11:5760143-5760144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541172185 | chr11:5760195-5760196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117768268 | chr11:5760201-5760202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181324442 | chr11:5760222-5760223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12787457 | chr11:5760241-5760242 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 23613489 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Ollier disease | 21235737 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5747400-5762400 | Weak transcription | Left Ventricle | heart |
2 | chr11:5756800-5760400 | Weak transcription | Ovary | ovary |
3 | chr11:5757400-5759800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr11:5757600-5760200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:5757800-5759600 | Enhancers | NHDF-Ad | bronchial |
6 | chr11:5757800-5759600 | Enhancers | Osteobl | bone |
7 | chr11:5757800-5759800 | Enhancers | HSMMtube | muscle |
8 | chr11:5757800-5760200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr11:5758400-5759600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr11:5758400-5759600 | Enhancers | HSMM | muscle |
11 | chr11:5759000-5759400 | Enhancers | NH-A | brain |
12 | chr11:5759400-5759800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr11:5761800-5762000 | ZNF genes & repeats | Gastric | stomach |
14 | chr11:5762600-5762800 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |